Neoadjuvant chemotherapy for symptomatic non operable grade II fibrillary astrocytoma in adults

被引:3
作者
Lebrun, C
Fontaine, D
Vandenbos, F
Chanalet, S
Bourg, V
Frénay, M
机构
[1] CHU Pasteur, Serv Neurochirurg, Nice, France
[2] CHU Pasteur, Serv Anatomopathol, Nice, France
[3] CHU Pasteur, Serv Radiol, Nice, France
[4] Ctr Lutte Canc, Nice, France
[5] CHU Pasteur, Serv Neurol, Nice, France
关键词
brain tumors; chemotherapy; low grade astrocytomas;
D O I
10.1016/S0035-3787(04)70982-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We collected 6 case-reports of symptomatric non removable low grade fibrillary astrocytoma of adults treated with a procarbazine-CCNU-vincristine chemotherapy regimen. All patients had drug-resistant epilepsy but brain imaging was stable. Total gross resection was rejected because of volume or tumor location. After 4 to 7 cycles of chemotherapy, 2 patients had partial response and one minor response on brain MRI. All of them were seizure-free. Progression free survival was not reached at 5 years. Up-front chemotherapy for low-grade astrocytomas may be useful and has to be prospectively evaluated.
引用
收藏
页码:533 / 537
页数:5
相关论文
共 33 条
[1]  
Béhin A, 2003, CANCER NEUROLOGY IN CLINICAL PRACTICE, P173
[2]   Nitroso-urea-cisplatin-based chemotherapy associated with valproate: Increase of haematologic toxicity [J].
Bourg, V ;
Lebrun, C ;
Chichmanian, RM ;
Thomas, P ;
Frenay, M .
ANNALS OF ONCOLOGY, 2001, 12 (02) :217-219
[3]   Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the Folstein Mini-Mental State Examination [J].
Brown, PD ;
Buckner, JC ;
O'Fallon, JR ;
Iturria, NL ;
Brown, CA ;
O'Neill, BP ;
Scheithauer, BW ;
Dinapoli, RP ;
Arusell, RM ;
Curran, WJ ;
Abrams, R ;
Shaw, EG .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (13) :2519-2524
[4]   The neurocognitive effects of radiation in adult low-grade glioma patients [J].
Brown, PD ;
Buckner, JC ;
Uhm, JH ;
Shaw, EG .
NEURO-ONCOLOGY, 2003, 5 (03) :161-167
[5]   Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: Efficacy and associations with chromosomal abnormalities [J].
Buckner, JC ;
Gesme, D ;
O'Fallon, JR ;
Hammock, JE ;
Stafford, S ;
Brown, PD ;
Hawkins, R ;
Scheithauer, BW ;
Erickson, BJ ;
Levitt, R ;
Shaw, EG ;
Jenkins, R .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) :251-255
[6]   Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas [J].
Cairncross, JG ;
Ueki, K ;
Zlatescu, MC ;
Lisle, DK ;
Finkelstein, DM ;
Hammond, RR ;
Silver, JS ;
Stark, PC ;
Macdonald, DR ;
Ino, Y ;
Ramsay, DA ;
Louis, DN .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (19) :1473-1479
[7]   Understanding low-grade glioma - A decade of progress [J].
Cairncross, JG .
NEUROLOGY, 2000, 54 (07) :1402-1403
[8]   Medical progress: Brain tumors [J].
DeAngelis, LM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (02) :114-123
[9]   Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions: functional results in a consecutive series of 103 patients [J].
Duffau, H ;
Capelle, L ;
Denvil, D ;
Sichez, N ;
Gatignol, P ;
Taillandier, STL ;
Lopes, M ;
Mitchell, MC ;
Roche, S ;
Muller, JC ;
Bitar, A ;
Sichez, JP ;
van Effenterre, R .
JOURNAL OF NEUROSURGERY, 2003, 98 (04) :764-778
[10]  
EAGAN RT, 1982, CANCER TREAT REP, V66, P1647